DK0517756T3 - Vævs-plasminogenaktivator med fibrinspecifikke egenskaber - Google Patents

Vævs-plasminogenaktivator med fibrinspecifikke egenskaber

Info

Publication number
DK0517756T3
DK0517756T3 DK91904945.2T DK91904945T DK0517756T3 DK 0517756 T3 DK0517756 T3 DK 0517756T3 DK 91904945 T DK91904945 T DK 91904945T DK 0517756 T3 DK0517756 T3 DK 0517756T3
Authority
DK
Denmark
Prior art keywords
variant
fibrin
plasminogen activator
tissue plasminogen
specific properties
Prior art date
Application number
DK91904945.2T
Other languages
English (en)
Inventor
John F Gill
Leonard G Presta
Mark J Zoller
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0517756T3 publication Critical patent/DK0517756T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK91904945.2T 1990-03-01 1991-02-14 Vævs-plasminogenaktivator med fibrinspecifikke egenskaber DK0517756T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/486,657 US5156969A (en) 1988-09-02 1990-03-01 Tissue plasminogen activator variant with deletion of amino acids 466-470 having fibrin specific properties

Publications (1)

Publication Number Publication Date
DK0517756T3 true DK0517756T3 (da) 1995-04-24

Family

ID=23932757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91904945.2T DK0517756T3 (da) 1990-03-01 1991-02-14 Vævs-plasminogenaktivator med fibrinspecifikke egenskaber

Country Status (10)

Country Link
US (1) US5156969A (da)
EP (1) EP0517756B1 (da)
JP (1) JP3081238B2 (da)
AT (1) ATE113983T1 (da)
AU (1) AU642984B2 (da)
CA (1) CA2075901C (da)
DE (1) DE69105121T2 (da)
DK (1) DK0517756T3 (da)
ES (1) ES2067221T3 (da)
WO (1) WO1991013149A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272076A (en) * 1991-06-13 1993-12-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
DE4423574A1 (de) * 1994-07-05 1996-01-11 Boehringer Mannheim Gmbh Nicht-glykosylierte Plasminogenaktivator-Derivate und ihre Verwendung bei erhöhtem Blutungsrisiko
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125269A1 (en) * 1982-11-11 1984-11-21 Beecham Group Plc Pharmaceutically active compounds
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
AU3876789A (en) * 1988-06-20 1990-01-12 Washington University Use of modified tpa to detect blood clots
DK395288D0 (da) * 1988-07-15 1988-07-15 Novo Industri As Proteiner
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE69113049T2 (de) * 1990-07-31 1996-04-04 Genentech, Inc., South San Francisco, Calif. Varianten des gewebeplasminogenaktivators mit vermindertem abbau.

Also Published As

Publication number Publication date
EP0517756A1 (en) 1992-12-16
JPH05504685A (ja) 1993-07-22
WO1991013149A1 (en) 1991-09-05
AU642984B2 (en) 1993-11-04
DE69105121D1 (de) 1994-12-15
AU7339891A (en) 1991-09-18
ES2067221T3 (es) 1995-03-16
CA2075901A1 (en) 1991-09-02
JP3081238B2 (ja) 2000-08-28
ATE113983T1 (de) 1994-11-15
CA2075901C (en) 2001-07-03
DE69105121T2 (de) 1995-05-04
EP0517756B1 (en) 1994-11-09
US5156969A (en) 1992-10-20

Similar Documents

Publication Publication Date Title
IL91306A (en) Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific properties
Gramse et al. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
DK0477274T3 (da) Faktor Xa baserede antikoaguleringspræparater
ATE70301T1 (de) Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
SE8702562D0 (sv) Novel fibrinolytic enzymes
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
Deguchi et al. Plasminogen activation by tissue plasminogen activator in the presence of platelets
Bergstein et al. Tissue plasminogen activator therapy of glomerular thrombi in the Shwartzman reaction
ATE114170T1 (de) Substitutionsvariante des gewebeplasminogenaktivators.
EP0487660B1 (en) Treatment of thrombotic events
ATE145669T1 (de) T-pa substitutionsvarianten mit verbesserter fibrinspezifität
IE890270L (en) Proteins derived from human alpha 2 plasmin inhibitor
EP0386240A4 (en) Novel polypeptide compounds
Dosne et al. Fibrinolysis in Endotoxemia